Author:
Yu Yi-ding,Xue Yi-tao,Li Yan
Abstract
AbstractHeart failure is the final destination of most cardiovascular diseases, and its complex molecular mechanisms remain largely uncertain. This study aimed to systematically investigate the underlying molecular mechanisms and diagnostic and therapeutic targets of heart failure using bioinformatics. We obtained 8 healthy samples and 8 heart failure samples from GSE8331 and GSE76701. After removing the batch effect, we performed a differential analysis on it and obtained 185 differentially expressed ID. The results of enrichment analysis showed that the molecular mechanisms of heart failure were mostly related to immune, inflammation, and metabolism-related pathways. Immune cell infiltration analysis showed that the degree of infiltration of Tgd cells and Neurons was significantly enriched in heart failure samples, whereas pDCs and NKTs were in healthy tissue samples. We obtained Hub genes including EGR1, EGR2, FOS and FOSB by PPI network analysis. We established a 4-gene diagnostic model with Hub gene, and validated it in GSE21610 and GSE57338, and evaluated the discriminative ability of Hub gene by ROC curve. The 4-gene diagnostic model has an AUC value of 0.775 in GSE21610 and 0.877 in GSE57338. In conclusion, we explored the underlying molecular mechanisms of heart failure and the immune cell infiltration environment of failing myocardium by performing bioinformatic analysis of the GEO dataset. In addition, we identified EGR1, EGR2, FOS and FOSB as potential diagnostic biomarkers and therapeutic targets for heart failure. More importantly, a diagnostic model of heart failure based on these 4 genes was developed, which leads to a new understanding of the pathogenesis of heart failure and may be an interesting target for future in-depth research.
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Hunt, S. A. et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult summary article. J. Am. Coll. Cardiol. 46(2005), 1116–1143. https://doi.org/10.1016/j.jacc2005.08023 (2005).
2. GBD Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet 392(10159), 1789–1858 (2017).
3. Maggioni, A. P. et al. EURObservational research programme: Regional differences and 1-year follow-up results of the heart failure pilot survey (ESC-HF Pilot). Eur. J. Heart Fail. 15, 808–817. https://doi.org/10.1093/eurjhf/hft050 (2013).
4. Yancy, C. W. et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation 136(6), e137–e161. https://doi.org/10.1161/CIR.0000000000000509 (2017).
5. Schultheiss, H. P. et al. Dilated cardiomyopathy. Nat. Rev. Dis. Primers. 5(1), 32. https://doi.org/10.1038/s41572-019-0084-1 (2019).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献